Inhibition of human α-thrombin by a phosphonate tripeptide proceeds via a metastable pentacoordinated phosphorus intermediate

被引:40
作者
Skordalakes, E
Dodson, GG
Green, DS
Goodwin, CA
Scully, MF
Hudson, HR
Kakkar, VV
Deadman, JJ
机构
[1] Natl Inst Med Res, Prot Struct Div, London NW7 1AA, England
[2] Thrombosis Res Inst, Dept Chem, London SW3 6LR, England
[3] Thrombosis Res Inst, Dept Biochem, London SW3 6LR, England
[4] Univ N London, Sch Biol & Appl Sci, Div Chem, London N7 8DB, England
关键词
human alpha-thrombin; tripeptide phosphonate; pentacovalent phosphorus; complex; transition state;
D O I
10.1006/jmbi.2001.4872
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
X-ray crystallographic studies of human alpha -thrombin with a novel synthetic inhibitor, an acyl (alpha -aminoalkyl)phosphonate, reveal the existence of a pentacovalent phosphorus intermediate state. Crystal structures of the complex of alpha -thrombin with the phosphonate compound were determined independently using crystals of different ages. The first structure, solved from a crystal less than seven days old, showed a pentacoordinated phosphorus moiety. The second structure, determined from a crvstal that was 12 weeks old, showed a tetracoordinated phosphorus moiety. In the first structure, a water molecule, made nucleophilic by coordination to His57 of alpha -thrombin, is bonded to the pentacoordinated phosphorus atom. Its position is approximately equivalent to that occupied by the water molecule responsible for hydrolytic deacylation during normal hydrolysis. The pentacoordinated phosphorus adduct collapses to give the expected pseudo tetrahedral complex, where the phosphorus atom is covalently bonded to Ser195 O-gamma. The crystallographic data presented here therefore suggest that the covalent bond formed between the inhibitor's phosphorus atom and O-gamma of Ser195 proceeds via an addition-elimination mechanism, which involves the formation of a pentacoordinate intermediate. (C) 2001 Academic Press.
引用
收藏
页码:549 / 555
页数:7
相关论文
共 19 条
[1]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[2]   Inhibition of trypsin and thrombin by amino(4-amidinophenyl)methanephosphonate diphenyl ester derivatives: X-ray structures and molecular models [J].
Bertrand, JA ;
Oleksyszyn, J ;
Kam, CM ;
Boduszek, B ;
Presnell, S ;
Plaskon, RR ;
Suddath, FL ;
Powers, JC ;
Williams, LD .
BIOCHEMISTRY, 1996, 35 (10) :3147-3155
[3]  
BODE W, 1992, PROTEIN SCI, V1, P426
[4]   SUBSTRATE-RELATED PHOSPHONOPEPTIDES, A NEW CLASS OF THROMBIN INHIBITORS [J].
CHENG, L ;
GOODWIN, CA ;
SCULLY, MF ;
KAKKAR, VV ;
CLAESON, G .
TETRAHEDRON LETTERS, 1991, 32 (49) :7333-7336
[5]  
Green D, 1999, PHOSPHORUS SULFUR, V144, P545
[6]   CATALYSIS IN ENZYME CRYSTALS [J].
HAJDU, J ;
ACHARYA, KR ;
STUART, DI ;
BARFORD, D ;
JOHNSON, LN .
TRENDS IN BIOCHEMICAL SCIENCES, 1988, 13 (03) :104-109
[7]  
HOLMES RR, 1980, PENIACOORDINATED PHO
[8]   EPISELECTION - NOVEL K-I-SIMILAR-TO NANOMOLAR INHIBITORS OF SERINE PROTEASES SELECTED BY BINDING OR CHEMISTRY ON AN ENZYME SURFACE [J].
KATZ, BA ;
FINERMOORE, J ;
MORTEZAEI, R ;
RICH, DH ;
STROUD, RM .
BIOCHEMISTRY, 1995, 34 (26) :8264-8280
[9]  
Kirby A. J., 1967, ORGANIC CHEM PHOSPHO
[10]  
MARTIN PD, 1992, J BIOL CHEM, V267, P7911